Log In
BCIQ
Print this Print this
 

JAK2 MutaSearch

  Manage Alerts
Collapse Summary General Information
Company Qiagen N.V.
DescriptionKit for detection of the janus kinase-2 (JAK-2) V617F allele in genomic DNA
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationHematology, Diagnostic
Indication DetailsDetect the janus kinase-2 (JAK-2) V617F mutation associated with myeloproliferative disorders (MPD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today